PHS 2006-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])

The summary for the PHS 2006-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
PHS 2006-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]): The purpose of this FOA from NIH is to invite eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) Phase I, Phase II, Fast-Track, and Phase II Competing Renewal grant applications through Grants.gov. This FOA will receive funds appropriated for fiscal years (FY) 2006 and 2007, the amounts for which are yet to be determined. However, the amount set-aside by NIH for FY 2005 STTR awards was $69 million. There are three standard, annual submission dates for NIH STTR grant applications: April 1, August 1, and December 1 (May 1, September 1, and January 2 for AIDS and AIDS-related applications). For planning purposes, the NIH estimates it will make 100 STTR awards for the FY 2006 cycles. This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, Fast-Track, and Phase II Competing Renewal applications, and runs in parallel with a FOA of identical scientific scope, PA-06-120! , that solicits NIH, Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA) applications under the Small Business Innovation Research (SBIR [R43/R44]) grant mechanisms. The CDC and the FDA do not participate in Fast-Track, Phase II Competing Renewal applications, and the STTR program.
Federal Grant Title: PHS 2006-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Federal Agency Name: National Institutes of Health
Grant Categories: Food and Nutrition Health Education Environment Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-121
Type of Funding: Grant
CFDA Numbers: 93.11393.114
CFDA Descriptions: Biological Response to Environmental Health Hazards 93.114 Applied Toxicological Research and Testing
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Jan 20, 2006
Creation Date: Jan 20, 2006
Archive Date: Feb 02, 2007
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.115 -- Biometry and Risk Estimation_Health Risks from Environmental Exposures
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Only United States small business concerns (SBCs) are eligible to submit STTR applications. A small business concern is one that, at the time of award, for both Phase I and Phase II awards, meets all of the following criteria: 1. Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the U.S. economy, and is organized for profit. 2. Is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. 3. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in Title 13 Code of Federal Regulations (CFR) Part 121. Business concer! ns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional...
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Opti...
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not...
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not...
Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com